Division of Gastroenterology and Hepatology, 159947Weill Cornell Medical Center, NY, USA.
531182KNG Health Consulting, Rockville, MD, USA.
Am Surg. 2021 Jul;87(7):1074-1079. doi: 10.1177/0003134820960049. Epub 2020 Dec 14.
Nasogastric tubes (NGTs) are used for decompression in patients with acute small bowel obstruction (SBO); however, their role remains controversial. There is evidence that NGT use is still associated with high incidence of aspiration pneumonia. The aims of this study were to define the prevalence of aspiration pneumonia in patients with SBO managed with an NGT and estimate the association of aspiration pneumonia with 30-day mortality rates, length of stay (LOS), and hospital costs.
A retrospective cohort study was done using Medicare Inpatient Standard Analytic Files from 2016 to 2018. Patients hospitalized with SBO and managed with NGT were identified using an algorithm of ICD-10-CM codes. The key exposure was aspiration pneumonia. Outcome measures included 30-day mortality rates, LOS, and hospital costs.
53 715 patients hospitalized with SBO and managed with an NGT were identified and included in the analysis. We observed a prevalence of aspiration pneumonia of 7.3%. The 30-day mortality rate was 31% for those who developed aspiration pneumonia vs. 10% for those without pneumonia ( < .001). Those with aspiration pneumonia, on average, were hospitalized 7.0 days longer ( < .001) and accrued $20,543 greater hospitalization costs ( < .001) than those without pneumonia. Controlling for hospital size and hospital teaching status, we noted a significant association between aspiration pneumonia and increased mortality ( < .001), longer length of stay ( < .001), and higher hospital costs ( < .001).
Among patients hospitalized for SBO who required an NGT, aspiration pneumonia was associated with a higher mortality rate, longer hospital LOS, and higher total hospital costs. vv.
鼻胃管(NGT)用于急性小肠梗阻(SBO)患者的减压;然而,其作用仍存在争议。有证据表明,NGT 的使用仍然与吸入性肺炎的高发率相关。本研究的目的是确定使用 NGT 治疗的 SBO 患者中吸入性肺炎的患病率,并估计吸入性肺炎与 30 天死亡率、住院时间(LOS)和住院费用的关系。
使用 2016 年至 2018 年的医疗保险住院标准分析文件进行回顾性队列研究。使用 ICD-10-CM 代码算法确定因 SBO 住院并接受 NGT 治疗的患者。主要暴露因素为吸入性肺炎。观察指标包括 30 天死亡率、住院时间和住院费用。
共纳入 53715 例因 SBO 住院并接受 NGT 治疗的患者进行分析。我们观察到吸入性肺炎的患病率为 7.3%。发生吸入性肺炎的患者 30 天死亡率为 31%,而无肺炎的患者为 10%(<0.001)。与无肺炎的患者相比,患有吸入性肺炎的患者平均住院时间延长了 7.0 天(<0.001),住院费用增加了 20543 美元(<0.001)。在控制医院规模和医院教学状况后,我们注意到吸入性肺炎与死亡率升高(<0.001)、住院时间延长(<0.001)和总住院费用增加(<0.001)之间存在显著关联。
在因 SBO 住院且需要 NGT 的患者中,吸入性肺炎与更高的死亡率、更长的住院时间和更高的总住院费用相关。